OR WAIT 15 SECS
In this week's news roundup from Rheumatology Network, we highlight key presentations that were made last week at the EULAR annual meeting.
There were plenty of interesting studies presented at the meeting, including one that showed high rates of remission in rheumatoid arthritis patients who are treated with conventional therapy.
In another, researchers reported that high disease activity in rheumatoid arthritis may be associated with venous thromboembolism.
And, EULAR issued a series of treatment recommendations: One outlines best practices during the COVID-19 pandemic and a second highlights recommendations for the use of platelet rich plasma injections for knee osteoarthritis.
In today’s one-on-one interview, we talk with E. Michael Lewiecki, M.D., an expert on osteoporosis and bone diseases. He is director of the New Mexico Clinical Research and Osteoporosis Center and a University of New Mexico program called Bone Health TeleECHO. A steering committee of the American Society for Bone Mineral Research recently issued COVID-19 treatment guidelines for patients receiving osteoporosis treatments. In this interview, Dr. Lewiecki he shares his best practices for treating osteoporosis patients during the pandemic.